TFF PHARMACEUTICALS, INC. Revenue
TFF PHARMACEUTICALS, INC. reported Revenue of $193.39 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. revenues for the quarter ending 2024-09-30 was $193.39K, a 17.62% decline year-over-year.
- TFF PHARMACEUTICALS, INC. revenues for the quarter ending 2024-06-30 was $650.22K, a 95.06% increase year-over-year.
- TFF PHARMACEUTICALS, INC. revenues for the quarter ending 2024-03-31 was $203.27K, a 295.25% increase year-over-year.
- TFF PHARMACEUTICALS, INC. revenues for the quarter ending 2023-12-31 was $114.33K, a 63.45% decline year-over-year.
- TFF PHARMACEUTICALS, INC. revenues for fiscal 2023 was $733.87K, a 48.02% increase from fiscal 2022.
- TFF PHARMACEUTICALS, INC. revenues for fiscal 2022 was $495.81K, a 462.39% increase from fiscal 2021.
- TFF PHARMACEUTICALS, INC. revenues for fiscal 2021 was $88.16K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2024-09-30 | $193.39K 10-Q · filed 2024-11-20 | $843.61K derived: sum of 2 quarters · filed 2024-11-20 | $1.05M 10-Q · filed 2024-11-20 | $1.16M derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-06-30 | $650.22K 10-Q · filed 2024-08-14 | $853.50K 10-Q · filed 2024-08-14 | $967.82K derived: sum of 3 quarters · filed 2024-08-14 | $1.20M derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-03-31 | $203.27K 10-Q · filed 2024-05-14 | $317.60K derived: sum of 2 quarters · filed 2024-05-14 | $552.36K derived: sum of 3 quarters · filed 2024-11-20 | $885.72K derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-12-31 | $114.33K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $349.09K derived: sum of 2 quarters · filed 2024-11-20 | $682.44K derived: sum of 3 quarters · filed 2024-11-20 | $733.87K 10-K · filed 2024-03-28 |
| 2023-09-30 | $234.76K 10-Q · filed 2024-11-20 | $568.11K derived: sum of 2 quarters · filed 2024-11-20 | $619.54K 10-Q · filed 2024-11-20 | $932.32K derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-06-30 | $333.35K 10-Q · filed 2024-08-14 | $384.78K 10-Q · filed 2024-08-14 | $697.56K derived: sum of 3 quarters · filed 2024-08-14 | $785.15K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $51.43K 10-Q · filed 2024-05-14 | $364.21K derived: sum of 2 quarters · filed 2024-05-14 | $451.80K derived: sum of 3 quarters · filed 2024-05-14 | $479.80K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $312.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $400.37K derived: sum of 2 quarters · filed 2024-03-28 | $428.37K derived: sum of 3 quarters · filed 2024-03-28 | $495.81K 10-K · filed 2024-03-28 |
| 2022-09-30 | $87.59K 10-Q · filed 2023-11-14 | $115.59K derived: sum of 2 quarters · filed 2023-11-14 | $183.03K 10-Q · filed 2023-11-14 | $195.02K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $28.00K 10-Q · filed 2023-08-14 | $95.44K 10-Q · filed 2023-08-14 | $107.44K derived: sum of 3 quarters · filed 2023-08-14 | $157.44K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $67.44K 10-Q · filed 2023-05-11 | $79.43K derived: sum of 2 quarters · filed 2023-05-11 | $129.43K derived: sum of 3 quarters · filed 2023-05-11 | $131.28K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $62.00K derived: sum of 2 quarters · filed 2023-03-31 | $63.85K derived: sum of 3 quarters · filed 2023-03-31 | $88.16K 10-K · filed 2023-03-31 |
| 2021-09-30 | $50.00K 10-Q · filed 2022-11-14 | $51.85K derived: sum of 2 quarters · filed 2022-11-14 | $76.17K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.85K 10-Q · filed 2022-08-11 | $26.16K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $24.32K 10-Q · filed 2022-05-11 |